ARENA, FLAVIA
 Distribuzione geografica
Continente #
NA - Nord America 52
EU - Europa 47
AS - Asia 30
SA - Sud America 1
Totale 130
Nazione #
US - Stati Uniti d'America 49
IT - Italia 33
CN - Cina 16
SG - Singapore 12
FI - Finlandia 8
DE - Germania 3
AT - Austria 2
CA - Canada 2
BR - Brasile 1
IE - Irlanda 1
JM - Giamaica 1
SA - Arabia Saudita 1
VN - Vietnam 1
Totale 130
Città #
New York 12
Singapore 11
Rome 9
Shanghai 9
Boardman 8
Helsinki 8
Milan 6
Ashburn 5
Seattle 3
Beijing 2
Serrone 2
Toronto 2
Washington 2
Boves 1
Changsha 1
Dallas 1
Dublin 1
Jinan 1
Los Angeles 1
Munich 1
Pavia 1
Riyadh 1
Santa Clara 1
Shenyang 1
Teresina 1
Totale 91
Nome #
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 32
Differential Kinetics of Effector and Memory Responses Induced by Three Doses of SARS-CoV-2 mRNA Vaccine in a Cohort of Healthcare Workers 24
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 23
Human Cytomegalovirus (HCMV) - specific T-cell response after letermovir prophylaxis is predictive for subsequent HCMV reactivation in haematopoietic stem cell transplant recipients 22
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 21
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 14
Totale 136
Categoria #
all - tutte 1.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202320 0 0 0 0 0 0 0 0 8 1 11 0
2023/202479 6 15 6 1 5 28 8 3 0 3 0 4
2024/202537 5 7 1 2 2 11 8 1 0 0 0 0
Totale 136